Skip to Main Content

Advertisement

Skip Nav Destination

A Phase II Trial of the Cyclin-dependent Kinase Inhibitor Flavopiridol in Patients with Previously Untreated Stage IV Non-Small Cell Lung Cancer1

Clin Cancer Res (2001) 7 (6): 1590–1599.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal